At least the damage at Theranos was confined to professional investors, Reuters writes in this opinion piece. Elizabeth Holmes’ blood-testing outfit touted novel technology and big future sales before its collapse. Holmes, whose trial starts today, blurred the lines between marketing and fraud, and Theranos’ multibillion-dollar private-market valuation dwindled to nothing. Fast forward and Trevor Milton, founder of electric-truck firm Nikola is facing similar charges. Nikola, though, has publicly traded shares. Read more.
Related Posts
SPACs Avoid Gender Diversity Push: Report
About half of 151 SPACs have no women on their board, Bloomberg reports.
Hong Kong’s First SPAC Gets Tepid Welcome
IPO of China Merchants-backed Aquila Acquisition just meets HKEX's $128m minimum for a listing.
Head of Engineering for Trump’s Truth Social App Resigns
The fledgling media company seeks to merge with Digital World Acquisition, although the deal has floundered almost from the day it was announced in October 2021.
Buffett: SPAC Mania Won’t Go on Forever
At the Berkshire Hathaway annual meeting this weekend, Warren Buffett explained how growing competition among SPAC funds for deals would lead to the industry's demise, Guru Focus reports.